Apellis Pharmaceuticals buy phonebroker
Start price
18.01.18
/
50%
€17.99
Target price
22.01.18
€18.94
Performance (%)
6.26%
End price
22.01.18
€19.11
Summary
This prediction ended on 22.01.18 with a price of €19.11. With a performance of 6.26%, the BUY prediction by phonebroker for Apellis Pharmaceuticals closed with a slight gain. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | -1.189% | -3.063% | 10.586% | 15.272% |
| iShares Nasdaq 100 | 3.663% | 8.732% | 34.914% | 58.325% |
| iShares Nikkei 225® | -1.422% | -0.414% | 3.883% | 4.190% |
| iShares S&P 500 | 2.182% | 4.907% | 28.279% | 51.241% |